GSK
About: In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Employees: 68,629
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
94% more call options, than puts
Call options by funds: $259M | Put options by funds: $133M
86% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 59
44% more repeat investments, than reductions
Existing positions increased: 356 | Existing positions reduced: 248
9.57% more ownership
Funds ownership: 8.86% [Q1] → 18.44% (+9.57%) [Q2]
3% more funds holding
Funds holding: 840 [Q1] → 868 (+28) [Q2]
2% more capital invested
Capital invested by funds: $14.2B [Q1] → $14.5B (+$321M) [Q2]
36% less funds holding in top 10
Funds holding in top 10: 14 [Q1] → 9 (-5) [Q2]
Financial journalist opinion
Based on 19 articles about GSK published over the past 30 days
